Cargando…
Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor
Protein microarray screenings identified fungal natural products from the azaphilone family as potent inhibitors of SARS-CoV-2 spike protein binding to host ACE2 receptors. Cohaerin F, as the most potent substance from the cohaerin group, led to more than 50% less binding of ACE2 and SARS-CoV-2 spik...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818685/ https://www.ncbi.nlm.nih.gov/pubmed/36611877 http://dx.doi.org/10.3390/cells12010083 |
_version_ | 1784865046428385280 |
---|---|
author | Jansen-Olliges, Linda Chatterjee, Shambhabi Jia, Lili Stahl, Frank Bär, Christian Stadler, Marc Surup, Frank Zeilinger, Carsten |
author_facet | Jansen-Olliges, Linda Chatterjee, Shambhabi Jia, Lili Stahl, Frank Bär, Christian Stadler, Marc Surup, Frank Zeilinger, Carsten |
author_sort | Jansen-Olliges, Linda |
collection | PubMed |
description | Protein microarray screenings identified fungal natural products from the azaphilone family as potent inhibitors of SARS-CoV-2 spike protein binding to host ACE2 receptors. Cohaerin F, as the most potent substance from the cohaerin group, led to more than 50% less binding of ACE2 and SARS-CoV-2 spike protein. A survey for structurally related azaphilones yielded the structure elucidation of six new multiformins E–J (10–15) and the revision of the stereochemistry of the multiformins. Cohaerin and multiformin azaphilones (1–5, 8, 12) were assessed for their activity in a cell-based infection assay. Calu-3 cells expressing human ACE2 receptor showed more than 75% and 50% less infection by SARS-CoV-2 pseudotyped lentivirus particles after treatment with cohaerin C (1) and cohaerin F (4), respectively. Multiformin C (8) and G (12) that nearly abolished the infection of cells. Our data show that multiformin-type azaphilones prevent the binding of SARS-CoV-2 to the cell entry receptor ACE2. |
format | Online Article Text |
id | pubmed-9818685 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98186852023-01-07 Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor Jansen-Olliges, Linda Chatterjee, Shambhabi Jia, Lili Stahl, Frank Bär, Christian Stadler, Marc Surup, Frank Zeilinger, Carsten Cells Article Protein microarray screenings identified fungal natural products from the azaphilone family as potent inhibitors of SARS-CoV-2 spike protein binding to host ACE2 receptors. Cohaerin F, as the most potent substance from the cohaerin group, led to more than 50% less binding of ACE2 and SARS-CoV-2 spike protein. A survey for structurally related azaphilones yielded the structure elucidation of six new multiformins E–J (10–15) and the revision of the stereochemistry of the multiformins. Cohaerin and multiformin azaphilones (1–5, 8, 12) were assessed for their activity in a cell-based infection assay. Calu-3 cells expressing human ACE2 receptor showed more than 75% and 50% less infection by SARS-CoV-2 pseudotyped lentivirus particles after treatment with cohaerin C (1) and cohaerin F (4), respectively. Multiformin C (8) and G (12) that nearly abolished the infection of cells. Our data show that multiformin-type azaphilones prevent the binding of SARS-CoV-2 to the cell entry receptor ACE2. MDPI 2022-12-25 /pmc/articles/PMC9818685/ /pubmed/36611877 http://dx.doi.org/10.3390/cells12010083 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Jansen-Olliges, Linda Chatterjee, Shambhabi Jia, Lili Stahl, Frank Bär, Christian Stadler, Marc Surup, Frank Zeilinger, Carsten Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor |
title | Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor |
title_full | Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor |
title_fullStr | Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor |
title_full_unstemmed | Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor |
title_short | Multiformin-Type Azaphilones Prevent SARS-CoV-2 Binding to ACE2 Receptor |
title_sort | multiformin-type azaphilones prevent sars-cov-2 binding to ace2 receptor |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818685/ https://www.ncbi.nlm.nih.gov/pubmed/36611877 http://dx.doi.org/10.3390/cells12010083 |
work_keys_str_mv | AT jansenolligeslinda multiformintypeazaphilonespreventsarscov2bindingtoace2receptor AT chatterjeeshambhabi multiformintypeazaphilonespreventsarscov2bindingtoace2receptor AT jialili multiformintypeazaphilonespreventsarscov2bindingtoace2receptor AT stahlfrank multiformintypeazaphilonespreventsarscov2bindingtoace2receptor AT barchristian multiformintypeazaphilonespreventsarscov2bindingtoace2receptor AT stadlermarc multiformintypeazaphilonespreventsarscov2bindingtoace2receptor AT surupfrank multiformintypeazaphilonespreventsarscov2bindingtoace2receptor AT zeilingercarsten multiformintypeazaphilonespreventsarscov2bindingtoace2receptor |